We are live on ! Find out more
EGA

Eagle Global Advisors Portfolio holdings

AUM $3.02B
1-Year Est. Return 34.37%
This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+34.37%
3 Year Est. Return
+104.69%
5 Year Est. Return
+141.45%
10 Year Est. Return
+266.5%
AUM
$3.02B
AUM Growth
+$245M
Cap. Flow
+$12.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
38.39%
Holding
301
New
25
Increased
98
Reduced
90
Closed
24
Avg Time Held
19.1 quarters
Top 10 Avg Time Held
10.9 quarters
Top 20 Avg Time Held
18.6 quarters

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$18.3M
2
EROK icon
EagleRock Land
EROK
+$15.1M
3
FTI icon
TechnipFMC
FTI
+$10.1M
4
VRT icon
Vertiv
VRT
+$9.99M
5
NFLX icon
Netflix
NFLX
+$9.86M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$13.7M
2
CVX icon
Chevron
CVX
+$11M
3
TRGP icon
Targa Resources
TRGP
+$8.82M
4
HON icon
Honeywell
HON
+$8.7M
5
TMUS icon
T-Mobile US
TMUS
+$8.49M

Sector Composition

Rank Sector Weight
1 Energy 38.73%
2 Technology 20.12%
3 Financials 9.42%
4 Industrials 7.63%
5 Communication Services 5.49%

No holdings matched the selected filter criteria.

Similar funds

Eagle Global Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Eagle Global Advisors held 301 positions worth $3.02B, up 8.8% from $2.78B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Eagle Global Advisors's Q2 2026 filing shows 25 new, 98 increased, 90 reduced and 24 closed positions. Its largest new stake was Eli Lilly: 17,945 shares worth $21.5M. The largest sale was Thermo Fisher Scientific, an estimated $13.7M.

By sector, the portfolio is most concentrated in Energy at 39% of assets, down from 42% a quarter earlier, followed by Technology and Financials.

  • Eagle Global Advisors's largest Q2 2026 buy was Eli Lilly: 17,945 shares worth $21.5M.
  • Eagle Global Advisors added most to Cameco in Q2 2026, an estimated $5.21M increase.
  • Eagle Global Advisors's biggest Q2 2026 reduction was Chevron, cutting an estimated $11M.
  • Eagle Global Advisors fully exited Thermo Fisher Scientific in Q2 2026, selling an estimated $13.7M.
  • Eagle Global Advisors's ten largest holdings make up 38% of its $3.02B portfolio in Q2 2026.
  • Eagle Global Advisors opened 25 new positions and closed 24 in Q2 2026.
  • Eagle Global Advisors's portfolio value rose 8.8% quarter-over-quarter to $3.02B.

Based on Eagle Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.